Back to results
US 2024/0173491 A1Published application
Integrated systems and methods of therapeutic administration
AssigneeNovastream Therapeutics Inc.
InventorsManuel Ornelas, Mark Webb, Jason Novak
Life of this patent
Estimating the term…
Abstract
The present disclosure provides systems and methods for administering medication to a subject, and convenient means for monitoring the subject's adherence to a treatment protocol (e.g., a recommended or prescribed treatment regimen).
Claims25
1-17. (canceled)
18:
- A nebulizer comprising:
- a cartridge including at least one reservoir including a medicament, wherein the cartridge is optionally replaceable;
- a nebulizing chamber in fluid communication with the at least one reservoir and including:
- a manifold configured to mix a portion of the medicament with a diluent, and
- a nebulizing mesh configured to vaporize the portion of the medicament;
- a power source configured to energize the nebulizing mesh;
- an exit port through which the vaporized portion of the medicament exits the nebulizer;
- and
- a logic module in operative communication with a remote software module and configured to limit use of the nebulizer in response to data received from the remote software module.
6 more elements
19:
- The nebulizer of claim 18 further comprising a hardware network module in operative communication with the logic module and configured to enable two-way data communication between the nebulizer and the remote software module.
20:
- The nebulizer of claim 18 further comprising a hardware security module in operative communication with the logic module and configured to prevent unauthorized dispensing of the medicament from the nebulizer.
21:
- The nebulizer of claim 18 further comprising at least one sensor in operative communication with the logic module and configured to detect at least one characteristic associated with a user's dispensation of the medicament from the nebulizer.
22:
- The nebulizer of claim 21, wherein the at least one sensor includes one or more of:
- a sensor for assessing a density of vapor emanating from the nebulizing mesh, a flow sensor for assessing an amount of vapor inhaled by a user through the exit port, a flow sensor for assessing an amount of the medicament withdrawn from the cartridge, a position sensor for assessing a change in position of a float or plunger associated with a volume of the medicament, and a pH sensor for assessing a pH level of vapor emanating from the nebulizing mesh.
23:
- The nebulizer of claim 18, wherein the cartridge includes more than one medicament reservoir each configured to store a medicament.
(canceled)
25:
- The nebulizer of claim 18, wherein the logic module is configured to control power provided to the nebulizing mesh from the power source in response to calibration data received from the remote software module.
26:
- The nebulizer of claim 21, wherein the logic module is configured to control power provided to the nebulizing mesh from the power source in response to calibration data received from the remote software module and in response to information obtained from the one or more sensors.
27:
- The nebulizer of claim 25, wherein the logic module is configured to cause the hardware security module to prevent power from flowing from the power source to the nebulizing mesh in response to security information received from the remote software module.
28:
- The nebulizer of claim 27, wherein the security information includes information associated with an authorized frequency of medicament dispensation.
29:
- The nebulizer of claim 21, wherein the logic module is configured to receive information obtained from the at least one sensor.
(canceled)
31:
- A method of securely dispensing a medicament to a user, the method comprising:
- specifying, in a remote software module, a treatment regimen for a user comprising one or more initial conditions of authorized dispensation of a medicament for the user;
- transmitting the treatment regimen information to a hardware device, wherein the hardware device comprises:
- a logic module,
- a power source in operative communication with the logic module and configured to provide power to a medicament delivery actuator,
- a hardware security module in operative communication with the logic module and configured to prevent unauthorized use of the hardware device,
- a cartridge comprising the medicament at a first concentration,
- a medicament vehicle module in fluid communication with the cartridge and including a medicament vehicle composition, and
- an input module in operative communication with the logic module and configured to detect a desired dispensation of the medicament when activated by the user;
- and
- permitting dispensation of the medicament to the user if and only if the activation of the input module by the user satisfies all initial conditions of authorized dispensation.
8 more elements
32:
- The method of claim 31, wherein the initial conditions of authorized dispensation comprise one or more of:
- a medicament name, a medicament dosage level, and a medicament dosage frequency.
33:
- The method of claim 31, wherein the step of permitting dispensation of the medicament comprises enabling, via the logic module, power to flow from the power source to the medicament delivery actuator upon activation of the input module by the user.
34:
- The method of claim 31 further comprising specifying, in the remote software module, a second treatment regimen for the user comprising one or more modified conditions of authorized dispensation of the medicament for the user that differs from the initial conditions of authorized dispensation.
35:
- The method of claim 34, wherein the second treatment regimen is specified by a clinician.
36:
- The method of claim 34, wherein the second treatment regimen is specified by an artificial intelligence or machine learning module associated with the remote software module.
37:
- The method of claim 36, wherein the artificial intelligence or machine learning module specifies the second treatment regimen based at least in part on an observed improvement in one or more characteristics of the user after an initial period of time.
38:
- The method of claim 36, wherein the second treatment regimen includes a test condition selected from a list of permitted modified conditions of authorized dispensation.
39:
- The method of claim 38, wherein the list of permitted modified conditions of authorized dispensation includes one or more of:
- a modified medicament dosage level, a modified medicament dosage frequency, a modified permitted medicament dispensation time of day, and a modified permitted medicament dispensation time relative to a time of consumption by the user of a second medicament or a meal.
(canceled)
(canceled)
Dependencies are inferred from the claim text.